← SynDRA
DORAVIRINE
SynDRA canonical compound SYN0037174 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | non-nucleoside reverse transcriptase inhibitor |
All known targets
- HIV RT
- pol
- reverse transcriptas
Mechanisms of action (all sources)
- non-nucleoside reverse transcriptase inhibitor
- Inhibitor
- pol INHIBITOR
Drug classes
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- pifeltro
- MK-1439
- Doravirina
- Mk-1439a
- Doravirine component of delstrigo
- Pifeltro
- MK 1439
- UNII-913P6LK81M
- MK1439
- 913P6LK81M
- DELSTRIGO COMPONENT DORAVIRINE
- doravirina
- Doravirinum
- RefChem:58186
- DTXCID5080877
- J05AG06
- Doravirine (MK-1439)
- MFCD22417167
- C17H11ClF3N5O3
- Doravirine [USAN]
- Doravirine [USAN:INN]
- 4ncg
- Pifeltro (TN)
- 2KW
- DORAVIRINE [MI]
- DORAVIRINE [INN]
- DORAVIRINE [JAN]
- Doravirine; MK-1439
- DORAVIRINE [WHO-DD]
- Doravirine (MK-1439)?
- Doravirine (JAN/USAN/INN)
- orb1303977
- SCHEMBL2509885
- DORAVIRINE [ORANGE BOOK]
- SCHEMBL29359533
- GTPL12679
- GLXC-90508
- HMS5085L08
Reported adverse events
- Dizziness
- Fatigue
- Headache
- Insomnia
- Nausea
- Pain
- Rash
- Sleep disorder
- Somnolence
- Stevens-Johnson syndrome
Look up DORAVIRINE in the interactive SynDRA portal →